학술논문
POSC113 Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in the Treatment of HER2-Positive Breast Cancer (HER2+ BC) Patients in Italy: A Budget Impact Analysis
Document Type
Abstract
Author
Source
In Value in Health January 2022 25(1) Supplement:S109-S109
Subject
Language
ISSN
1098-3015